In vitro effects of ethanol and mouthrinse on permeability in an oral buccal mucosal tissue construct

Food and Chemical Toxicology

Volumn 49, Issue 10, 2011, Pages 2524-2529

  Koschier, Francis ^a   Kostrubsky, Vsevolod ^a   Toole, Colleen ^b   Gallo, Michael A ^c  

^a JOHNSON AND JOHNSON   (United States)

^b CeeTox Inc   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

EpiOral buccal tissue; Ethanol and mouthwashes; Ethanol metabolism; Human oral mucosa; Mucosal permeability; Toxicity of ethanol

Indexed keywords

ACETALDEHYDE; ACETIC ACID; ALCOHOL; CAFFEINE; MOUTHWASH;

ALCOHOL METABOLISM; ARTICLE; CELL VIABILITY; CHEEK MUCOSA; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DIFFUSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; MEMBRANE PERMEABILITY; MEMBRANE TRANSPORT;

ACETALDEHYDE; ACETIC ACID; CAFFEINE; CHEEK; CULTURE MEDIA; ETHANOL; HUMANS; LINEAR MODELS; MOUTH MUCOSA; MOUTHWASHES; PERMEABILITY; TISSUE CULTURE TECHNIQUES;

EID: 80051878326     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2011.06.018     Document Type: Article

References (24)

1. Barnett M.L. The rationale for daily use of antimicrobial mouthwash. J. Am. Dent. Assoc. 2006, 137(Suppl.):16S-21S.
2. Cha Y., Sachan D. Acetylcarnitine-mediated inhibition of ethanol oxidation in hepatocytes. Alcohol 1995, 12:289-294.
3. ChemAgilent, 2010. http://www.chem.agilent.com/Library/applications/5989-9665EN.pdf.
4. Dong Y.J., Peng T.K., Yin S.J. Expression and activities of class IV alcohol dehydrogenase and class III aldehyde dehydrogenase in human mouth. Alcohol 1996, 13:257-262.
5. Javed A., Hassan N., Ahad A., Mushir A. Chemical permeation enhancers for transbuccal drug delivery. Expert Opin. Drug Deliv. 2010, 7(1):97-112.
6. Klausner M., Ayehunie S., Breyfogle B.A., Wertz P.W., Bacca L., Kubilus J. Organotypic human oral tissue models for toxicological studies. Toxicol. In Vitro 2007, 21:938-949.
7. Lachenmeier D.W., Gumbel-Mako S., Sohnius E.M., Keck-Wilhelm A., Kratz E., Mildau G. Salivary acetaldehyde increase due to alcohol-containing mouthwash use: a risk factor for oral cancer. Int. J. Cancer 2009, 125:730-735.
8. Lieberman M., Marks A.D., Smith C.M. Marks' Essential Medical Biochemistry 2006, 353.
9. Martel F., Keating E., Calhau C., Azevedo I. Uptake of (3)H-1-methyl-4-phenylpyridinium ((3)H-MPP(+)) by human intestinal Caco-2 cells is regulated by phosphorylation/dephosphorylation mechanisms. Biochem. Pharmacol. 2002, 63:1565-1573.
10. Moreno A., Pares A., Ortiz J., Enriquez J., Pares X. Alcohol dehydrogenase from human stomach: variability in normal mucosa and effect of age, gender, ADH3 phenotype and gastric region. Alcohol Alcoholism 1994, 29(6):663-671.
11. Moharamzadeh K., Brook I.M., Van Noot R., Scutt A.M., Thornhill M.H. Tissue-engineered oral mucosa: a review of scientific literature. J. Dent. Res. 2007, 86:115-124.
12. Moharamzadeh K., Franklin K.L., Brook I.M., Van Noot R. Biologic assessment of antiseptic mouthwashes using a three-dimensional human mucosal model. J. Periodontol. 2009, 80:769-775.
13. Poggi P., Rodriguez Y., Baena R., Rizzo S., Rota M.T. Mouthrinses with alcohol: cytotoxic effects on human gingival fibroblast in vitro. J. Periondontal. 2003, 74:623-629.
14. Riveros-Rosas H., Julian-Sanchez A., Pina E. Enzymology of ethanol and acetaldehyde metabolism in mammals. Arch. Medical Res. 1997, 28:453-471.
15. Roguet R., Lotte C., Patouillet C., Zanini M., Messager A. Permeation and skin absorption: reproducibility of various industrial reconstructed human skin models. Skin Pharmacol. Skin Physiol. 2002, 15(Suppl. 1):18-30.
16. Silverman S., Wilder R. Antimicrobial mouthrinse as part of a comprehensive oral care regimen. Safety and compliance factors. J. Am. Dent. Assoc. 2006, 137(Suppl.):22S-26S.
17. Smetanova L., Stetinova V., Kholova D., Kvetina J., Smetana J., Svoboda Z. Caco-2 cells and Biopharmaceutics Classification System (BCS) for prediction of transepithelial transport of xenobiotics (model drug: caffeine). Neuro Endocrinol. Lett. 2009, 30(Suppl.1):101-105.
18. Thakur R., Michniak B., Meidan V. Transdermal and buccal delivery of methylxanthines through human tissue in vitro. Drug Develop. Ind. Pharm. 2007, 33:513-552.
19. Waters, Analysis of Caffeine and Metabolites Using XBridge C18. http://www.waters.com/waters/library.htm?lid=1532020.
20. Walle T., Walle U.K., Sedmera D., Klausner M. Benzoapyrene-induced oral carcinogenesis and chemoprevention: studies in bioengineered human tissues. Drug Metab. Dispos. 2006, 34:346-350.
21. Watson R.R. Diagnosis of Alcohol Abuse 1989, vol. 12. CRC Press, Boca Raton, FL.
22. Welk A., Rosin M., Ludtke C., Schwann C., Kramer A., Daeschlein G. The peritoneal explant test for evaluating tissue tolerance to mouthrinses. Skin Pharmacol. Physiol. 2007, 20:162-166.
23. Zang H., Robinson J.R. In vitro methods for measuring permeability of the oral mucosa. Oral Mucosa Drug Delivery 1996, 85-100. Marcel Dekker Inc., NY.
24. Yokoyama A., Tsutsumi E., Imazeki H., Suwa Y., Nakamura C., Mizukami T., Yokoyama T. Salivary acetaldehyde concentration according to alcoholic beverage consumed and aldehyde dehydrogenase-2 genotype. Alcohol Clin. Exp. Res. 2008, 32:1607-1614.